Search

Your search keyword '"Wilcken, N"' showing total 224 results

Search Constraints

Start Over You searched for: Author "Wilcken, N" Remove constraint Author: "Wilcken, N"
224 results on '"Wilcken, N"'

Search Results

2. Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary

3. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary

6. Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study

8. 91MO Randomized trial of neoadjuvant chemotherapy with or without concurrent aromatase inhibitor therapy to downstage ER+ve breast cancer: Breast Cancer Trials Group ANZ 1401 ELIMINATE trial

13. Third consensus on medical treatment of metastatic breast cancer

15. Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study.

16. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

17. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

21. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

22. Two truncating variants in FANCC and breast cancer risk

23. Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases

24. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

26. Second consensus on medical treatment of metastatic breast cancer

28. Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases.

29. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

30. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

31. Two truncating variants in FANCC and breast cancer risk

32. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

33. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials

34. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

35. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

36. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

39. Abstract OT2-04-03: Examining personalized radiation therapy (EXPERT): A randomised phase III trial of adjuvant radiotherapy vs observation in patients with molecularly characterized luminal A breast cancer

40. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years

41. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

42. Platinum-containing regimens for metastatic breast cancer

43. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

44. Hope, optimism and survival in a randomized trial of chemotherapy for metastatic colorectal cancer

46. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

48. Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

49. Physical activity and fitness in women with metastatic breast cancer

50. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Catalog

Books, media, physical & digital resources